Anti-tumor peptide molecule with multiplex targeting performance and selectivity and application thereof
A dual-targeting, anti-tumor technology, applied in anti-tumor drugs, medical preparations containing active ingredients, peptide/protein components, etc., can solve problems such as fever, leukopenia, and susceptibility to infection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Synthesis of anti-tumor peptide molecules with dual targeting and selectivity (take the synthesis of 0.25mmol peptide molecules as an example)
[0033] 1. Materials
[0034] (1) Weigh 0.982g of MBHA resin with a loading capacity of 0.318mmol / g, and swell in DCM overnight;
[0035] (2) Prepare a DMF (dimethylformamide) solution of the following amino acids at a concentration of 0.2mol / L:
[0036] Fmoc-Ala-OH (N-fluorenylmethoxycarbonyl-alanine): volume 11mL, mass 0.82g;
[0037] Fmoc-Gly-OH (N-fluorenylmethoxycarbonyl-glycine): volume 56mL, mass 1.90g;
[0038] Fmoc-Pro-OH (N-fluorenylmethoxycarbonyl-proline): volume 11mL, mass 0.74g;
[0039] Fmoc-Ile-OH (N-fluorenylmethoxycarbonyl-isoleucine): volume 32mL, mass 2.26g;
[0040] Fmoc-Lys(Boc)-OH(N-fluorenylmethoxycarbonyl-N'-tert-butoxycarbonyl-lysine): volume 32mL, mass 3.00g;
[0041] Fmoc-Arg(Pbf)-OH(N-fluorenylmethoxycarbonyl-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-arginine): volume 84mL, mass 10.92g;...
Embodiment 2
[0054] Cytotoxicity test of anti-tumor polypeptide molecules with dual targeting and selectivity
[0055] First inoculate 100 μL of a sterile 96-well plate at a density of 1×10 5 Cells / mL cells were placed in a 37°C incubator for 24 hours. After they adhered to the wall, the culture solution in the well plate was sucked out, and 100 μL of fresh culture solution and 100 μL of filtered polypeptide solutions of different concentrations were added to each well. Set up 4 parallel Abs for each concentration peptide In addition, the wells that only added Tris (trihydroxymethylaminomethane) buffer and no peptide were used as the control group Abs Tris , and then put the well plate back in the incubator at 37°C for 48h. After the effect was completed, 20 μL of MTT (3-(4,5-dimethylthiazole-2)-2 at a concentration of 5 mg / mL was added to each well. , 5-diphenyltetrazolium bromide) solution, continue culturing in the incubator for 4 hours, then suck out the liquid in the well plate, add...
Embodiment 3
[0059] Enzyme test
[0060] Prepare peptide molecules with pH 7.0 Tris buffer:
[0061] Ac-Arg-Gly-Asp-Gly-Pro-Leu-Gly-Leu-Ala-Gly-Ile-Ile-Ile-Gly-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-NH2 (RR22) solution, the concentration of which is 100 μM, a part of the solution is taken out and added to matrix metalloproteinase MMP7, and the sample is characterized by mass spectrometry.
[0062] The result is as figure 2 as shown, figure 2 The mass spectrum of (a) and figure 2 (b) all show that matrix metalloproteinase MMP7 can successfully enzymatically hydrolyze polypeptide molecules and release amphiphilic
[0063] Leu-Ala-Gly-Ile-Ile-Ile-Gly-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-NH2 (LR15) fragment.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com